Sign in to continue:

Wednesday, April 29th, 2026

Auburn National Bancorporation Reports 43% Increase in Q1 2026 EPS and Strong Asset Quality




Auburn National Bancorporation, Inc. Reports Significant Growth in Q1 2026 Results

Auburn National Bancorporation, Inc. Delivers Strong Q1 2026 Earnings, Asset Quality, and Loan Growth

Key Highlights for Investors

  • Earnings per share (EPS) soared by 43% year-over-year, reaching \$0.63 for Q1 2026 (up from \$0.44 in Q1 2025).
  • Net interest income grew 10% year-over-year to \$7.8 million, driven by higher loan balances and improved net interest margin.
  • Net interest margin (tax-equivalent) expanded by 19 basis points to 3.28%, reflecting improved asset yields and lower deposit costs.
  • Annualized loan growth of 12% was achieved in Q1 2026, signaling robust demand and business momentum.
  • Return on assets (annualized) improved significantly to 0.86%, up from 0.62% in Q1 2025.
  • Nonperforming assets plummeted to just 0.01% of total assets, indicating exceptional asset quality.
  • Noninterest expense remained well controlled, essentially unchanged year-over-year at \$5.9 million despite higher revenue.
  • Shareholders’ equity rose to \$93.1 million (\$26.62 per share) from \$83.1 million (\$23.79 per share) a year ago.

In-Depth Financial Performance Review

Auburn National Bancorporation, Inc. (Nasdaq: AUBN), parent of AuburnBank, reported a strong first quarter of 2026, underscoring the company’s robust financial health and operational progress. Net earnings reached \$2.2 million (\$0.63 per share), marking a substantial increase from both the previous quarter (\$1.7 million, \$0.48 per share) and the same period last year (\$1.5 million, \$0.44 per share). This performance was propelled by solid net interest income and an expanded net interest margin, complemented by ongoing strength in mortgage lending income.

Revenue & Earnings Drivers

  • Net Interest Income: Reached \$7.8 million, up from \$7.1 million in Q1 2025, due to growth in average interest-earning assets and an improved net interest margin.
  • Net Interest Margin: Increased to 3.28% from 3.09% last year, benefiting from higher yields on earning assets, a lower cost of interest-bearing deposits, and a more favorable asset mix.
  • Average Loans: Rose to approximately \$577.5 million, compared to \$566.1 million in Q1 2025.
  • Noninterest Income: Increased to \$0.9 million, primarily due to higher mortgage lending income.

Asset Quality & Credit Trends

  • Nonperforming Assets: Declined sharply to just \$0.1 million (0.01% of total assets), following the charge-off of one nonperforming loan.
  • Net Charge-Offs: Rose to \$402,000 (0.28% of average loans, annualized), primarily related to the charged-off loan, compared to \$64,000 (0.05%) in Q1 2025.
  • Allowance for Credit Losses: Ended at \$6.8 million (1.16% of total loans), down from 1.27% at year-end 2025, reflecting refinements in the CECL calculation and the establishment of a new, lower-risk municipal loan segment.
  • Provision for Credit Losses: Recorded a negative provision of \$(76,000) for Q1 2026, indicating a release of reserves, compared to a positive \$783,000 provision in Q4 2025.

Expense Management & Efficiency

  • Noninterest Expense: Held steady at \$5.9 million, despite increases in salaries, benefits, and professional fees (offset by lower occupancy and equipment expenses).
  • Efficiency Ratio: Improved to 67.63% from 74.82% a year ago, demonstrating better operating leverage.

Capital Strength & Shareholder Returns

  • Stockholders’ Equity: Increased to \$93.1 million (\$26.62 per share), up from \$83.1 million (\$23.79 per share) in Q1 2025.
  • Equity-to-Assets Ratio: Remained strong at 9.06%.
  • Dividends: The company paid a cash dividend of \$0.27 per share during the quarter.
  • Regulatory Capital Ratios: Well above the “well-capitalized” standards.

Noteworthy and Potentially Price-Sensitive Items

  • Major EPS Growth: The 43% year-over-year increase in EPS is likely to be a positive catalyst for the share price, especially given the consistent dividend and capital strength.
  • Exceptional Asset Quality: Nonperforming assets fell to just 0.01% of total assets, reflecting very strong credit discipline. The charge-off of the single problematic loan and subsequent reserve release (negative provision) may be viewed very positively by investors.
  • Loan Growth and Margin Expansion: Double-digit loan growth and higher margins suggest successful execution on core banking strategies and potential for continued earnings momentum.
  • Expense Control: Holding expenses steady while growing revenue and improving efficiency is a strong sign of operational discipline.
  • Shareholder Returns: Book value per share rose, and the dividend was maintained, supporting the investment case for income-focused investors.

About Auburn National Bancorporation, Inc.

Auburn National Bancorporation, Inc. is the parent company of AuburnBank, an Alabama state-chartered bank with \$1.0 billion in assets. The bank has operated continuously since 1907 and serves East Alabama with seven branches and a loan production office.

Outlook and Cautionary Note

Management remains confident in the company’s asset quality, capital, and liquidity. However, investors should note the company’s forward-looking statements, which are subject to various risks and uncertainties, including changes in economic conditions, interest rates, loan demand, and regulatory policies. The company does not undertake to update forward-looking statements.

Disclaimer

This article is based on Auburn National Bancorporation, Inc.’s Q1 2026 earnings press release and should not be considered as investment advice. Investors should conduct their own due diligence and consult with financial advisors before making investment decisions. The company’s results are subject to various risks as outlined in its SEC filings, and past performance is not indicative of future results.




View AUBURN NATIONAL BANCORPORATION, INC Historical chart here



Merit Medical Acquires View Point Medical to Expand Breast and Soft Tissue Tumor Localization Portfolio

Merit Medical Systems Acquires View Point Medical: Detailed ...

Rubrik, Inc. Announces Strong Financial Results and Key Product Innovations for Fiscal Year 2026

Rubrik, Inc. Reports Q4 and FY2026 Results: Key Investor Hig...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today